Cytochrome
P450s from Schmidtea mediterranea (planarian, flatworm, Platyhelminthes)
Last
modified Oct. 13, 2008 D. Nelson
Powerpoint slide of a Planarian P450 tree
CYP2 clan (50 sequences, some are partials, 39
complete sequences)
Planarian clade A
>v31.024852 35 24% to #5
31% to v31.005723
MIYIILILLLVICLLINKLIYSFKDPPGPIGIPFIGIF
PVVLFKKLFRIKSNENKFFMEMHKIYGNIWSFRIINQRYVVLGAPELQTEAFKHSGMTLS
GRPLTELYKYVSKRRGVLSSDGQIWVLYRKLTTKALHEISHKTRGFEDVITENIKLLLNY
IDRNPDSIRTSNLFHSMTLTIIFKIVFNIDTDFDDEKIKKYIKNVQIITSSNLTFSNAVF
PLTNVPLLKYCVPSVLRIKKAMDNNVNILTELWKESKENCETNELESSSIGEFYLKQLQL
TKVYEEEHQHLNDMNFIRNFSDIVGAGSDTVAATLAWCCLLLADRVKIQNKLRSEINEFV
EVKSVIFFSYSDKSQLPYLCSFIEEVHRYFTIIPRTVHRPMKNLIFHGYKLLENDIILGD
SYTSNHNADIWPNADKFIFDRFVENKEEKIKHLQENFYPFGTGKRNCIGESLARKEVLLT
LVALICHYKIELTNESKLNFEEILNGENGLVFAPFCHNLKFSRISN*
>v31.005980 39 26% to #5
94% to v31.000094, 94% to v31.009749. 93% to
v31.010860
81% to v31.013885, 81% to v31.012632
MIIMFYVNYAPKSNEPPGPISVPFLGVIPYI
IYKSILLKKKLNQKLLFQQLKKHYGEISKFYIGDQRIVLLSSFDIISEAYVKNKFIFNGR
PRIFGLDILSDNFKGLMLSEKKIWKENRSTTVKSFHDLGVGRKEFNDLSVANIESMCEWI
RECQGKEFDVNRILFKTFLKIMNSLIFGHEPEETESNIYDIYETICFLAQTDFTETQILW
KYRSFSAVKKLFPMFEKYANKVSMLHKYIELKVQRKLKYLTEDPNEECLIKYYINKQMEN
SEIFICCVDLYLAGVDTVSSFVSACLLLLGKHQHFQEKIKIEIENLENTVNPITYEHKRF
FPFTQAFIEECHRYFAVVPAIERRPMEEVILKGYLIKSTDLIIGEQYSLNFNSTIWENPN
EFNPYRFIKEENGNFQPNSYLIPFGIGGRTCLGEIIGRTETFNSIVAIVSKFNVSLSMET
SGNCDKILEGTSGGIRHSPLDHTLVFTENVEK*
>v31.013885 37 23% to #5
MLFYCLWLIFILTIILLSITYSLKSNEPPGPIS
VPLFGVVPYIIYKSILLKKKLNQKLIFQQLKKDYGEISKFYIGDQRIVLLSSFDIISEAY
VKNKFIFNGRPRMVGLDILSDDFKGLLLNEGTMWKQNRSTTVKSFHNLGVGRKEFNDLSV
ANIESMCEYLREFQGKELDVKTILIKTFLKIMNSVIFGHETEETKSNILEIYEIIVFLTQ
TDFTVFQIFWQYRSFPGVKKLFPILENYANKVSIIHNYIKLKAQWKLRDLTEDPNEECLF
NIYRNEQIEYSEILQCCVDLYLAGVDTVSSIVSACLLLLGKHQHFQEKIKIEIKNLENTV
NPITYEHKRFLPFTQAFIEECHRYFITIPTFQHRVVKEVILKGYLIKPTDVIIGEQYSLN
FNSTIWENPNEFNPYRFIKEENGNFQPNCYLIAFGIGGRTCLGEVIGKTEIFNSIVSIVS
KFNVSLSMETTENYDKILEGTSGGIVHSPLDHTLVFTENLEKY*
>v31.009749
N-term runs off the end
CIHIESMCEWIRECQGKEFDVNRILFKTFLKIMNSLIFGHEPEETESNIYDIYETICFLA
QTDFTETQILWKYRSFSAVKKLFPMFEKYANKVSMLHKYIKLKVQRKLKYLTEDPNEECL
IKYYINKQMENSEIFICCVDLYLAGVDTVSSFVSACLLLLGKHQHFQEKIKIEIENLENT
VNPITYEHKRFLPFTQAFIEECHRYFAVIPAIERRPMEEVILKGYLIKPTDLIIAQQYSI
DYDSTLWENPNEFNPYRFIKEENGNFQPNSYLIPFGIGGRTCLGEVIGRNETFNSIVAIV
SKFNVSLSMETSGNYDKILEGTSGGILHSPLDHTLVFTENVEK*
>v31.000094 pseudogene &= frameshift
94% to v31.005980
MLFYFIWLSVCFLLMIIIFYVNYAPKSNEPPGPISVPFLGVIPYIIYKSILLKKKLNQKL
IFQQLKKDYGEISKFYIGDQRIILLSSFDIISEAYVKNKFIFNGRPRIFGIDILSDDFKG
LMLSEKKIWKENRSTTVKSFHDLGVGRKEFNDLSVSNIESMCEWIRECQGKEFDVNRILF
KTFLKIMNSLIFGHEPEETESNIYDIYETICFLAQTDFTKTQILWKYRSFSAVKKLFPML
EKFE &
NKVSMLHKY
IKLKVQRKLKYLTEDPNEECLIKYYINKQMENSEIFICCVDLYLAGVDTVSSFVSACLLL
LGKHQHFQEKIKIEIENLENTVNPITYEHKRFLPFTQAFIEECHRYFAVIPGIERRPMEE
VILKGYLIKPTDLIIGEQYSLNFNSTI*ENPNEFNP*RFIKEENSNFQPNSYLIPFGIGG
RTCLGEIIGKTETFNSIVAIVSKFNVSLSMETSGNYDKILEGISGGILHSPLDHFSIY*
>v31.010860 partial C-term pseudogene
TQILWKYRSFSAVKKLFPMLEKFE &
NKVSMLHKYIKLKVQRKL
NYLTEDPNEECLIKYYINKQMENSEIFICCVDLYLAGVDTVSSFVSACLLLLGKHQHFQE
KIKIEIENLENTVNPITYEHKRFLPFTQAFIEECHRYFAVVPAIERRPMEEVILKGYLIK
PTDLIIAQQYSIDYDSTLWENPNEFNPYRFIKEENGNFQPNSYLIPFGIGGRTCLGEVIG
RNETFNSIVAIVSKFNVSLSMETSGNYDKILEGTSGEILHSPLDHTLVFTENVEK
> v31.012632 36 24% to #5
MLFYCLWLIFILTIILLSISYSLKSNEPPGPISVPLFGVIPYIIYK
SILLKRKLNQKLIFQQLKKDYGEISKFYIGDQRIVLLSSFDIISEAYVKNKFIFNGRPRM
VGLDILSDDFKGLILNEGTMWKQNRSTTVKSFHNLGVGRKEFNDLSVANIESMCEYIREF
QGKELDVKTILIKTFLKIMNSVIFGHETEETKSNILEIYEIIVFLSQTDFTVFQVFWQYR
SFPGVKKLFPILEKYANKVSIIHNYIKLKAQWKLRDLNEDPNEECLFNIYRNEQIEYSEI
LQCCVDLYLAGADTVSSIVSACLLLLGKHQHFQEKIKIEIENLENTVNPITYEHKRFLPF
TQAFIEECHRYFITIPTFQHRVVKEVILKGYLIKPTDVIIGEQYSLNFNSTIWENPNEFN
PYRFIKEENGNFQPNCYLIAFGIGGRTCLGEVIGKTEIFNSIVSIVSKFNVSLSTETTEN
YDKILEGTSGGIVHSPLDHTLVFTENVEKY*
>v31.005723 40 25% to #5 stop codon in frame
MNIIFGVLFVLIYVFLKHFYRRKSHPPGPLGFPIVGMFPYSILKI
IFSKFIINESESEFFRQMKQKYGGIWSIESCGQRIITLASFDILHEAFVDNGMLFSGCSQ
NSLVELYGNKRGILFVDGDIWKRNRHTVLKVLRILGMGTSTMEKLISEHVDCLIKDLKKR
SGIPIDPSKEFLKLTSDVINIINFNEPNDENDPNFRTYILNLEKYTNSYLRYIIFVWPWF
FLSKFGRFLFPKIEEYVNAIDINRRFVAEKCMSRLKVFSESPNLKCSFDYIWYHKVLNEA
SKDQNCDMDVLNVIQIMTDLQNAATETTFNLLKFRCLLLSRYPDVQNDLRNELYNLVEDS
AQITLNLKNKCPKLLSFINEVHRFCNLVPKVGHRVIR*CTFRGFELDTRDIVLGDINSIM
FDENNFNNPQLFDPYRFLNEMRTEYVYSKFFIPFGIGKRTCLGENLANMEINLILSRILY
EFQISLSHETDKHFETILEGKFGIIHSCLNHELVFHALWQNH*
>v31.000479a 33 24% to #5 16-17k
MNIIIGVIFVFILLFLRHFYKRKSHPPGPLGFPIFGIFPYSITQIIFSK
FMTNVSECEYFKQMRQKYGSIWSIETVGQRIITLASFDIVHEAFVENGMLFSGCAQNSLV
ELYGGKRGILFVDGAIWKQNRHLAIKALTTMGMGTSALEKLNCEQADCLIKEIKQKSGIQ
IDPRKEFVKAIANIINIVNFNEPNNENDPKFEKYMLCLEKFANSHIKHIIFIWPSFFLSK
LGRFLFPKVEEYVNAIYNNRRLVADKCMSRLKVFNQSSDLKCVFDYIWKNEDFIEDLNDQ
SFNVKIFNVIQIMTDLQNAGTETTYNLLRFCCLLLGRYPEVQDDLRNELQNLVEDSTQIT
LNLKNKCPKLLSFIGEVHRFCNLVPKVGHRVMKKFIFRGFEFDTSDMVFADFNSIMFDEN
HFDNPQKFDPYRFLDETRTKYIPSQHLIGFGIGRRTCIGESLANMEIFFLLSRIIFEFQI
SLSNETVEHFAKIFEGEIGIMRTSLYHELVFHSVSKI*
>v31.000479b 31 24% to #5 27-29k
MNIIIGVIFVFILLFLRHFYKRKSHPPGPLGFPIFGIFPYSITQIIFSKFMTNVSECEY
FKQMRQKYGNIWSIETVGQRTITLASFDIVHEAFVENGMLFSGCAQNSLMELFGNRHGIL
FADGIIWKRNRHLAMKGLRYFGMGTSTMEKLICEQADCLIKEIKQKSGIQIDPSKIFVKN
ISNIINIVNFNEPNNENDPKFEKYVSCLDKISNSHIKHIIFIWPSFFLSKLGRFLFPKVE
EYVNAIYNNRRLVADKCMSRLKVFNQSSDLKCMFDYIWRNEDFIEDLNDQSYDVKLFNVI
QIMTDLQNAGTETTYNLLRFCCLLLGRYPEVQDDLRNELQNLVEDSIQITLSLKNKCPKL
LSFIDEVHRFCNLVPKSDHRVMKKCFFRGFDFYPSDMVFADYNAIMFDENHFDNPQKFDP
YRFLDETRTEYTPSKYLIPFGMGRRTCIGENLSNMEIFLFLSRILYEFHISLLNETVEHF
TEILKGETGIIHSCLNHELIFQSSGKVSSFIG*
> v31.021522 30 26% to #5
MFLDCFIVFISLLSATERSSWPNWMARFWINTGKTILVLTGSKYSQSKCYSEMKDKYGAL
WSRKLFHIREIVFTSYELIYETLVIHGTQFSNRPKDLPILDYVSKKGGIIFIGGKYWKAH
RKDTLKIMHKLGMTNLTIEDKVVQESEKLLQEIFKSANKPIESDKLYSKPVMNIICQLML
NRSFEYDDQKFINVIKNIQVIGQDGNVHFLFYMRSIINFWIFREAFKSVRIFMDNLEELE
EWVESQLDATSEKFNPEFDNPSCILEHYLVLQKQQESNGESSDLYSKHQIIRNCFDIYSA
GIDTTTHMLCWCTLMLGLKPDFQTRIRNEIKANKSNSAMNFNTTKSFHFFKAFLDECFRY
FPVIPRIAHAVEKPIYFKGFHLVPRDLLMMDFKAMSKDPDIWKDPEEFDPFRFMDETRHL
YKPNKHLIAFGIGKRSCMGENLARCELTIILLSIIQTFEIKLTQNTLENINLIISGTEGL
IYAPLEHEIIYIPI*
> v31.008063 38 24% to #5
MFIEVLCFLIVLLFLYHYYQ
RQKDPPGPIGWPVFGSTPERLYWYLTGRKYSQSKCYSEMKEKYGALWSRKLFHIKEIVFA
SYELIYESLVIHGTQFSNRPKDLPILDYVSKKGGIIFIGGKYWKAHRKDTLKIMHKLGMN
NLTIEDKVVQESEKLLQEIFKSANKPVESDKLYSKPVMNIICQLMLNRSFEYDDQKFINV
IKNIQVIGQDGNVHFLFYMRSIINFWIFRETFKSVRIFMDNLEELEEWVESQLDATSEKF
NPEFDNPSCILEHYLVLQKQQESNGESSDLYSKHQIIRNCFDIYSAGIDXXXXNHR-ISH
TKSFHFFKAFLDECFRYFPVIPRIAHAVEKPIDFKGFHLVPRDLLMMDFKAMSKDPDIWK
DPEEFDPFRFMDETRHLHKPNKHLIAFGIGKRSCMGENLARCELTIILLSIIQNFEIKLT
QNTLENINLIISGTEGLIYAPLEHEIIYIPI*
> v31.023906 34 24% to #5
MFIEVLCFLIVLLFLYHYYQRQKDPPGPIGWPVFGSTPERLYWYL
TGRKYSQSKCYSEMKDKYGALWSRKLFHIREIVFASYELIYETLVIHGTQFSNRPKDLPI
MDYVSKKGGIIFIGGKYWKAHRKDTLKIMHKLGMNNLTIEDKXXXXKIIATNLGMNN-P-
RQGIQESEKLLQEIFKSANKPVKSDKLYSKPVMNIICQLMLNRSFEYDDQKFINVIKNIQ
VIGQDGNVNLLFFMRSIINFWIFRETFKSVRIYMDNLEELEKWVESQLDATSEKFNPEFD
NPSCILEHYLVLQKQQESNGESSDLYSKHQIIRNCFDIYGAGIDTTTHMLCWCTLMLGLK
PDFQTRIRNEIKANKSNSAMNFNTTKSFHFFKAFLDECFRYFPVIQRAVHAVEKPIDFKG
FHLVPRDLLMMDFKTMSKDPDIWKDPEEFDPFRFMDETRHLHKPNKHLIAFGIGKRSCMG
ENLARCELTIILLSIIQTFEIKLTQNTLENINLIISGTEGLIYAPLEHEIIYIPI*
>v31.028126 29 25% to #5
MFIEVLCFLIVLLFLYHYYQRQKDPPGPIGWPVFG
STPERLYWYLTGRKYSQSKCYSEMKEKYGALWSRKLFHIREIVFASYELIYESLVIQGTQ
FSNRPKDLPIMDYVSKKGGIIFIGGKYWKAHRKDTLKIMHKLGMNNLTIEDKVVQESEKL
LQEIFKSANKPVKSDKLYSKPVMNIICQLMLNRSFEYDDQKFINVIKNIQVIGQDGNVNL
LFFMRSIINFWIFRETFKSVRIYMDNLEELEEWVESQLDATSEKFNPEFDNPSCILEHYL
VLQKQQESNGESSDLYSKHQIIRNCFDIYGAGIDTTTHMLCWCTLMLGLKPDFQTRIRNE
IKANKSNSPMNFNTTKSFHFFKAFLDECFRYFPVIQRAVHAVEKPIDFKGFHLVPRDLLM
MDFKTLSKDPDIWKDPEEFDPFRFMDETRHLYNPNKHLIAFGIGKRSCMGENLARCELTI
ILLSIIQTFEIKLTQNTLENINLIISGTEGLIYAPLEHEIIYIPI*
Planarian clade B
>v31.000423 19 43% to #5
MILVVLFCITVYVFYKFYLRKTSSALPSHLKPIPV
VSGGLPIVGNLLNVSSAPFQYLNDLREKYGPIYSIQIGWKNIIVLNNYDVINKSLKEQGN
TFSGRWANVFTKDLAKDSGILFKDKEFWATQRSFTLRVLRDFGFGKQCAENVVYREIEKM
VKEIKLKNGRNIETTKLVSFATVNMISDFIMKREFENNDENILYVIKSIQDIARVADVNS
LVMNVFPIFDWFPRISLMLIYYFHPMRIIQTIDRTTDFIGSIVEDHRKRFCPENESQDLI
DAFLLEQHRLNSLNSKNHSFTDWQVVRLISELFLAGYETTANTLSWTFLLLAIHPEIQTK
IRDEISKEIGFIRWPTMNDKKSLNYCQAVLDEIFRYSTVLPLSIAHRVLENASINGFFVP
ADSILFPNLYACHRDPSVWKKPYDFYPEHFLNENGNYQPKVELVPFGLGKRQCLGEALAR
MEEFIVVVSFLQKFSISLSDESKKLDTFQLLNGSRGTFRGPAIHTLNFDELVH*
>v31.001047 28 32% to #5 AIG aligns with CIG no CYS
39% to v31.003777
MAWHIIFAVAYLILGLVLVSVLHGKKRKPRFSDQEKPKLNDV
STIKSYLFYSLPIYRNLSVFRLKYGNFFSLKLGMRKITFINNFDLIKQIMYGKEDTFSGK
WKPKMQSFTNDRSDYLKEQERIVTQRNFNNKLLKDFLTEKSKLCSTISMECQHFLKELER
SNEKSLNISNMVSLFSFNIFFSLLLDKRFEVKDPKFRTLQDTMTIEIKKRNFLYIFHLLF
PFIENSKFTAKFLIWMLSRTKIYKEFNEIFDDELRAHLKPIENNLEHDDLITYIQSMKYY
STSLSSSVRKSFDKKLIVNSYETISSDYEIISSILLWSMFFMSYFPEVQKKVHEEIVYVI
GKERMPEMKDKENLHYTQAVMDEILRLGSPVFLGAFYRAFKDISIENNIIPQNSLMFINL
YGCHTDPKLWEKPFDFYPNHFLNKSDSNQTTYSPREELLIFGIDKKQAIGESLTRAQYFL
LFASIFQKFKVNSSENISTNKFKEIIRNSDGMVRTPSIKNYVFHIL*
>v31.005628 22 41% to #5
MLILIILFVLCFLICFRLLNFKRNLPKGLKECPLVKSW
PIVGILPQIKAPMYDFFMKLAKTYGPIYRIRFGMREMVILNNDDLVRKALVNNSDSFSGR
STTQKYTFLCMNSGIIFLDNHVWSIQRPFLSKVLRDFGMGNCKSVEIAQSECLMLLDDLA
KKGGQSVDVKNLFYDCTANIIAKFVMNKRVTSTDSLFRLMKDMQNRIVKQKDLVQFFLLM
FPIFDSWDWFNRFFVFITFRHRIFERIHVKWQEVIEDHLKTVDFDCEGDDLIERFLIKKN
QLLQQEKSVKTFTDMQLIRNSLELFVAGFDTTATTLVWSMMFMAKHIKIQEQVYDEIIDK
IGKERLPTLSDKKSLSYTQAVIDEILRMSSVAPMAIIHRTTKDAVVDGYFIPENTLIIPN
IYACHYDPKIWETPNEFSPNHFLSKNSTGELKYKAREELIPFSLGKRQCLGESLARTEFF
IFFTTILQRFRVQFSKPLSDSDYRSAIRGNDGVLRVCSVTDYSFEIRD*
>v31.001287 27 40% to #5
MIYFIILALFIIAYFLVRSRKKDSRMIPIEKGLPL
VGVLLKLKYPVLDYYEKLARKHGPLFRMRIGMRDIFVLNNYDTIRKAFVENGNNFAGRWK
LFQALVVTNNSGLVSIDGDLWHMHKAFVLNVMHKCVTSFDNTQEECLCLLEELESLNKKV
INLSEVIRVYTVNIISRFVLNKRFNRDNPIFTFLSKMSLEFAERADIFQFIFFTLPIFDK
LPGICRLLIDFTDRGRKFRKAQNIFQEEIEEHRKRLDLDSEGEDLIDCFLIKQHQLKSTT
GSVGSFTDIQLIQSSLELFIAGFETTSTILEWSFLFMARYNDIQENVYKEIVDKIGKERL
PTMKDRKQLVYTQAVMDEVYRLSSISPLAIIHRVVNDCNIDGYFIPKDSLVQSNIWGCHT
DPNVWERHKEFYPHHFLKTDAAGNIKYDPKQELNAFGIGKRQCIGESLARMEYFIFFTSV
MQRFHVNFAKSVNEIEFDSAIRGCDGIIRSPVSLKDYIFTRRK*
>v31.000183a 23 42% to #5 169-170k
MIIICIITIILGVTIYWKLIKRTSISKGLKIIPTEKGLPFVGVLHQMETPILKYYERLIKKHGSV
FAVRYGMRDVIILNDYQTVKSAFVDDGSNYSGRWRLVSSLLAANNSGIAFIDGQNWQTQR
TFMLKVLHDFGMGKSVSYEIVRQECFNLLEELETLQGKRVDASDLIHLYTVNIISKFTMN
KRFSRGDDKLRNINDLITHVAKQKDLLQFWFFALPIFDKMPLLCDWIISRTHRIKHFDAV
HKYFQEEVDEHRKSLDLNSEGEDLIDRFLIKQHQLKASTGSIEGFTDFQLLRMSLELLIA
GLETTTTTLEWSFLFMSKYTIIQQKVHEEIVNIIGKERFPTTNDRKDLNYTQAVMDEIFR
VSSVAPLALVHRAMNDSSINGYYVPKDALVFSNLYACHFDEKVWEKPKEFYPERFLSTDI
NGDIKYTANENLNAFGMGKRRCAGESLAKMEAFIFFTSIMQRFEVRFSEDVSDALYEEAL
IGNDGLVRCSKINKFIFTKRE*
>v31.000183b 24 41% to #5 176-178k
MIWFFLLILISVVALLFNFLRPRPIPKGLQKVPIEKGFPLIGILPLLTFPIL
EYYERLIKKHGPVFGMKMGLRTIFVLNDYRAIRNALIDNKDNFSGRWRLFQSLLGTQNAG
IVSTDGDQTHIHRRFIIKVMHEFGMGTLRSLTNIQTECTALLECLEKCQGERIQVSDIIP
TYMANIITKFLMNKTFSVGDPKLNLIKNILTEIARTKDIFQFLYFTLPILDRFPRVCDFL
MSFTTRKDLFNKVHRILQQEIEEHRKTFDVKNEGEDLIDRFLMKQDQLKSSEESVKSFTD
FQLVRHLLELFLAGYETTSTIFHWSLFFMSKYQEIQSKVHQEIIDSIGTERLPTNNDRKD
LTYTTAVMDEILRLSSVLPLALIHRTTNDTEVNSYFIPKDSLVLINLYACHVDPNVWEKP
REFYPEHFLSPKENGNIKYVPKDQLNPFGMGKRQCIGESLGRMQYFIFFVSILQRFQVSF
ADPVTESQFQEALRANEGIVRYPSINEFVFNRIQ*
>v31.000183c 25 39% to #5 181-183k
MIIIYLCTFLLGAAI
FWKFTRRTPIPKGLRRIPTEKGLPFVGVLHQIETPIFRYYERLIKKHGSVFAVRYGMRDV
IILNDYQTVKSAFVDDGSNYSGRWKVSQSLLMSGYARIAFIDGEMWQIQRPFVLKVFHDF
GIGKSVSYEIARQECLYLIDELETLNGKWVDVSDLIHLYTVNIISKFITNKRFSRKEDKY
KTIGNLGQQALKQKDCLQLLFYTLPLFDKMTWLCDWILRRTNRKVLFDAVDKLVQEEIDE
HRKTLDLNSEGEDLIDRFLIKQHQLKASTGSSKQFTDFQLRRLSLELLLAGLETTTTSLE
WSFLFMSKYTIIQQKVHEEIVNIIGKERFPTLNDKKDLHYTQAVIDEIFRVSSVGPLALV
HRAMNDSSINGYHVPKDSLVYSNLYACHFDEKVWEKPKEFYPERFLSTDINGDIKYKAND
SLNPFGVGKRRCTGESLARMEIFVFFTSIMQRFEVRFAEDVSDALYEEALIGNEGIVRGS
KIKNYIFTKLK*
> v31.003865 26 40% to #5
MIIIYLCTFLLGAAIYWKFIRLTSIPKELKRIPTEKGLPII
GVLHKIESPILRYYERLIKKHGSVFAVRFGMRDVIILNDYQTVKSAFVHDGSNYSGRWKV
SQSLMMSGNAGIAFIDGEMWQTQRTFMLKVFHDFGMGKSVSYEIVRQECHFLIDELETLI
GKCVDVSDLIQLYTVNIISKFIMNKRFSRKEDKYKRLSDLSQHALKQKDFFQFLFYTLPL
FDKMNWLCDWILRRTNRRIPFDAVDKLVQEELDEHRKTLDLNSEGEDFIDRFLIKQHQLK
TSTGSSEQFTDFQLLRLSMELLVAGLETTMTTLGWSFLFMSKYTNIQKKVHNEIIKTVGK
ERFPTLNDRKYLHYTQAVMDEVIRVSSVAPLAFVHRAMEDSSLNGYYVPKDSLVFSNLYA
CNFDEKVWKKPKEFYPEHFLSTDINGVIIYTPNESLNPFGVGKRRCVGESLARMEIFVFF
TSIMQRFEVKFAEDVSEALYEEALIGNEGVVRSSKIKNFIFEKLG*
>v31.003664a 18 41% to #5 6-7k
MILILCSFCIILILYYFGKR
WRSGQRILRNQAPLVKGLPLIGSLLDIKLPLHIYLKELSEIYGPVYRIKLGFREILVFNS
FEILKQTFKLDGNSFSGRWSTCLFKVLTHDSGIFLKDGEVWVKQRAFVQKVLRDFGVGRS
KSSETVQFECESCLDEIKLLVGKKVDFSQLIPIYTLNIISKFIMNKRFCREDPKIKMIEN
VLLEFLKKADFVTMFYLVFPCFENSSLVFKILMKLQAHLKMVIEIHDSFKKEIESHQKVL
DLNSDGEDMIDRFLLEQKRVREKTGSIDTFTEWQLIRNSFEMLVAGYETTSTTLVWSLMF
MSRHQDIQEKVYKEIVSVIGKEKLPSISDKKDMDYTQAIMDEILRMSSVTPLASFHRAMI
DCSAKGFFVPKDTLIFPNLYACHFDPDVWINPSEFYPNHFLSTDDNIPMKYCPREELIPF
GIGKRQCLGESLARMEYFIFFCSILQRFKVRFAEEMTEMRYQEVLRGNDGVIRICLETNF
IFEERQL*
> v31.003664b 41 17-21k gap in middle
MILILFSFCIILILYYFGKRWRSRQRILRNQAPLVKGLPLIGSLLDIK
LPLHIYLKDLSQIYGPVYRIKLGFREILVFNSFEILKQTFKLDGNSFSGRWSTCLFKVLT
HDSGIIFTDGEVWAKQRAFMQKVLRDFGVGRXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXX-WQRYETTSTTLVWSLMFMSRHQDIQEKVYKEIVSVIGKEKLPSINDKKDMDYT
QAIMDEILRLSSVTPLASFHRAMIDCSAKGFFVPKDTLIFPNLYACHFDPDVWSNPSEFY
PNHFLSTDDNIPMKYCPREELIPFGIGKRQCLGESLARMEYFIFFCSILQRFKVRFAEEM
TEMRYQEVLRGNDGVIRICLETNFIFEERQL*
>v31.003664c 42 possible pseudogene or
partial seq that runs off the end
MILILF
SFCIILILYYFGKRWRSCQRILRNQAPLVKGLPLIGSLLDIKLPLHIYLKDLSQIYGPVY
RIKLGFREILVFNSFEILKQTFKRDGNSFSGRWSTCLFKF &
QVLTHDSGIIIYRWAKFGLNSHHLLQKGLKRISGVGKSKSSE
>v31.041651 17 42% to #5
MILILFSFC
IILILYYFGKRWRSRQRILRNQAPLVKGLPLIGSLLDIKLPLHIYLKDLSQIYGPVYRIK
LGFREILVFNSFEILKQTFKLDGNSFSGRWSTCLFKVLTHDSGIIFTDGEVWAKQRAFMQ
KVLRDFGVGRSKSSEIVQFECESCLDEIKQLAGKKVDFSQLIPIYTLNIISKFIMNKRFC
REDPKLKFMQKMMLDSLKKIDFVLIFYLVFPYFENSSLVFKFFMKLTTHLKMVLKIYDSL
NEEIETHQKLLDWNSDGEDMIDRFLLEQKRVMEKTGSVETFTKWQLIRNSFEMLVAGYET
TSTTLVWSLMFMSRHQDIQEKVYKEIVSVIGKEKLPSINDKKDMDYTQAIMDEILRLSSV
TPLASFHRAMIDCSAKGFFVPKDTLIFPNLYACHFDPDVWSNPSEFYPNHFLSTDDNIPM
KYCPREELIPFGIGKRQCLGESLARMEYFIFFCSILQRFKVRFAEEMTEMRYQEVLRGND
GVIRICLETNFIFEERQL*
> v31.007336 16 42% to #5
MILILFSFCIILILYYFGKRWRSRQRILRNQAPLVKGLPLIG
SLLDIKLPLHIYLKDLSQIYGPVYRIKLGFREILVFNSFEILKQTFKLDGNSFSGRWSTC
LFKVLTHDSGIIFTDGEVWAKQRAFMQKVLRDFGVGRSKSSEIVQFECESCLDEIKQLAG
KKVDFSQLIPIYTLNIISKFIMNKRFCREDPKLKFMQKMMLDSLKKIDFVLIFYLVFPYF
ENSSLVFKFFMKLTTHLKMVLKIYDSLNEEIETHQKLLDLNSDGEDMIDRFLLEQKKVME
KTGSVDTFTEWQLIRNSFEMLVAGYETTSTTLVWSLMFMSRHQDIQEKVYKEIVSVIGKE
KLPSINDKKDMDYTQAIMDEILRMSSVTPLASFHRAMIDCSAKGFFVPKDTLIFPNLYAC
HFDPDVWSNPSEFYPNHFLSTDDNIPMKYCPREELIPFGIGKRQCLGESLARMEYFIFFC
SILQRFKVRFAEEMTEMRYQEVLRGNDGVIRICLETNFIFEERQL*
>v31.003777a 14 46% to #5 9-10k 3
exons pseudogene
MIFIIFISFIGICGLYFLINLKN
RNTSISVGLKNLPIVRGIPIFGILFQKKGPFHIYLKNLGHKYGSIFSIKFGMREVVVLNK
(small deletion)
RTFVLKVFRDFGFGKSRSYEIVESECKFMLEELKSLQ
KTILDFYNFIPIYTANIISKFIMNKRFERTDPKIKAIEFAIFQTTKKSNILQILHLMFPK
LDDSFIISTFTLWLTSRRKLFSGIEKVFEEEIQEHLENLDFNSEGNDLIDRFLIEKQRLV
QSTGNHQGFTDKQLIFMTFELFGAGYETTSTTLGWSMVFMARYPHIQNKVFDEIRENIGL
EKIPIMNDKKSLTYTQAVMDEILRLSSVAPLGIYHRTFSDTSVDNFFIPKNSLIFPNYFA
CHTDPETWRKPFEFFPEHFISSTENGELKYTPREDLVPFGIGKRQCI
()
GESLAKMEFFIFFVSIFQSFEVKFAENISDKLYQENLEGNDGIIRYSKIKNFIFHKRDVNN*
>v31.003777b 15 46% to #5 17-19k
MMFLLFISFIGICGLYFLIN
LKNRNTSISVGLKNLPIVRGIPIFGILFQKKEPLHIFLKNLGHKYGSIFSIKFGMREVVV
LNNFRIIKKTLKDEGDNFSGRWQTKLKTVISLNTGILFIDGDHWHTQRTFVLKVLRDFGF
GKSRSYEIVESECKFILEELKSLQETVVDISKLIPIYTANIISKFIMNKRFERTDPKIKA
IEFAIFQTTKKSNILQILHLMFPKLDDSFIISTFTLWLTSRRKLFSGIEKVFEEEIQEHL
ENLDFNSEGNDLIDRFLIEKQRLVQSTGNHQGFTDKQLIFMTFELFGAGYETTSTTLGWS
MVFMARYPHIQNKVFDEIRENIGLEKIPIMNDKKSLTYTQAVMDEILRLSSVAPLGIYHR
TFSDTSVDNFFIPKNSLIFPNYFACHTDPETWRKPFEFFPEHFISSTENGELKYTPREDL
VPFGIGKRQCIGESLAKMEFFIFFVSIFQSFEVKFAENISDKLYQENLEGNDGIIRYSKI
KNFIFHKRDVNN*
>v31.001148 21 42% to #5
MDLIYYVVFLLTFVFVYFWTFKKDRLPNGQREVPTAYGLPL
IGVIHKIKPTLPYYLLRLGKELGPIFSIKLGMRKVFVLNSYDSIKKALVDDGYNFSGRWK
TKLFSDFLHDSGVLFTDGKLWETQRSFILYVLRDFGFGKSRSIEMVQDECSNFIEEIDTL
VGQTLNFSTLIPIYSMNIISRFITNRRYTRDDPMIQLIEESGRKLLTNKDKAQFILLMFP
IFEQSTLFVKLIQHISSVKFIIPV-KYFAEIIEEHREALDFNSEGEDLIDRFLKKQRQLE
QSTGNFWTFHNWQMIQSACELFFAGSETSSTTLTWSCLFMSRYPDIQKKVHNEIVEIIGI
ERLPTMNDKRSLNYTQAVMDEILRLSSVVPLSIFHRTFEDANINGYYIPKNSMIFPNLFA
CHVDPDLWTNPMTFDPEHFLKLETDGTLKYRPREELIPFGIGKRQCIGESLARIEFFIFF
TRMMQRFRISFAEELSEEQYSKVLISDDAPVKSCQITDYIFHRL*
>v31.000808 20 42% to #5
MDLIFYVVSLLTFVFIYFWTFKKDRLPNGQREVPAAYG
LPLIGVIHKIKPTLPYYLLRLGKELGPIFSIKLGMRKVFVLNSYDSIKKALVDDGYNFSG
RWKTKFFSDFIHDSGVLFTDGKLWETQRSFILNVLRDFGFGKSRSVEMVQEECSNFIEEL
DTLVGQTLNFSTLIPIYSMNIISRFITNRRYTRDDPMIQLIEESGRKVLTNKDKAQFILL
MFPIFEQSTLFAKFMQLTSSWKSLIPVQEYFAEIIEEHREALDFNSEGEDLIDRFLINQH
QLQQRNGNIETFNNWQMIRNASELFIAGSETSSTTLTWSCLFMSRYPDIQKKVHNEIVEI
IGRERLPTMNDKRLLNYTQAVMDEILRLSSVVPLSVFHRTFEDANINGYYIPKNSLIFPN
LFACHVDPDLWTNPMTFDPEHFLKLETDGTLKYRSRKELIPFSIGKRQCIGESLARIEFF
IFFTRMMQRFRISFAEELSEEQYSKVLISDDAPVKSCQITDYIFHRL*
>v31.001324a 9 46% to #5 44-45k
MELCYCVTFILIFLYFLYWVCRKPPIPKGLKEIPMESGLPIIGAIHKIEPPMHHYLLKLGR
KLGPIFRIKLGMRKIVVLNNYEMIKKALIDDANNFSGRWSQRFIKEITHDSGIIFKDGKI
WATQRSFILKVLRDFGLGKSKSIEIVQNECFNFLDELDTLSGQIVDFSELIPIYTTNIIS
RFIMNKRFTRDDPNIQLIEETINNSTKNKDIIQLILLMFPCFDNSSLICQLIYLLTSKWK
SFVKIQNYFGEEIEEHRTNLDLTSEGEDLMDRFLIKQHELKQSTGNVESFVDWQLIRTSV
ELFIAGYETTSTTLNWCCLFMSKYPDIQEKVHKEISEIIGKERLPTMNDKKALNYTQAVM
DEVLRLSSVAPMGLIHRTFDDANINGFYIPKDSLIFPNLYACHMDPEIWESPTTFYPEHF
LSLDSNGISKYQPREELIPFSVGKRQCLGESLARSEYFIFFVSMVQRFQISFAEEISEDK
YSQTIIGNEGVIRTSDIKNFLFKRR*
>v31.001324b 10 45% to #5 47-48k
MELCYCVTFILIFLYFLYWV
CRKPPIPKGLKEIPMESGLPIIGAIHKIEPPMHHYLLKLGRKLGPIFRIKLGMRKIVVLN
NYEMIKKALIDDANNFSGRWSPKVDAEVTHDSGIIYKDGKIWATQRSFILKVLRDFGLGK
SKSIEIVQNECFNFLDELDTLSGQIVDFSELIPIYTTNIISRFIMNKRFTRDDPNVHFME
KAITKFTKNKDIFQLILLMFPCFDNSSLICQLIYLLTSEWKSFIRTQDFFADEIKEHRNA
LDFTSEGEDLMDRFLIKQYQLKQSTGNVESFVDWQLIRTSVELFIAGFETTSTTLNWCCL
FMSKYPDIQEKVHKEISEIIGKERLPTMNDKKALNYTQAVMDEVLRLSSVVPMALIHRTF
HDANINGFYIPKDSLIFPNLYACHMDPEIWEFPKTLYPEHFLSLDSNGISKYQPREELIP
FSVGKRQCIGESLARSEYFIFFVSMVQRFQISFGEEISEDRYSQTIIGNEGLIRTSDIKN
FLFKRR*
>v31.001324c 11 46% to #5 64-66k
MELCYCVTFILIFLYFLYW
VCRKPPIPKGLKEIPMESGLPIIGAIHKIEPPMHHYLLKLGRKLGPIFRIKLGMRKIVVL
NNYEMIKKALIDDANNFSGRWSPKIITEVSHDSGIMFKDGQGLATQRSFILKVLRDFGLG
KAKSLEIIQNECLNLLDELDTFSDQIVDFSEFFPIYTTNIISRFIMNKRFTRDDPNIQFI
WKTMDNLAKNKDIFHLILLMFPCLDQSFIVARLLFLFVSDWKRFVKIQDYFAEEIKEHRN
ALDFTSEGEDIMDRFLIKQHELKQSTGNVESFVDWQLIRNSVELFIAGFETTSTTLNWCC
LFMSKYPDIQEKVYKEISEIIGKERLPTMNDKKAMNYTQSVMDEVLRLSSVSPLSLIHRT
FHDANINGFYIPKDSLIFPNLYACHMDPEIWESPTTFYPEHFLSLDSNGISKYQPREELI
PFSVGKRQCLGESLARSEYFIFFVTMVQRFQISFGEEISEEKYLQTIIGNEGLIRTSDIK
NFLFKRR*
>v31.001324d 12 44% to #5 81-83k
MELCYYVTFILISLFFYYWTFKKTQIPKGLKEIPVESGLPIIGAIHKIEMPISRYFQKLSRKLGPIF
RIKLGMRKIVVLNNYEMIKKTLIDDANNFSGRWLPKVFTDAAHDSGIMFKDGHIWAIQRS
FLLKVLRDFGLGKAKSLEIIQNECLNFLDELDTLSGQIVEFSELIPIYTTNIISRFIMNK
RFTRDDPKVQFIGKTITNLTKSKDILQLILIMFPCFDTSSLFSKLVFLLNTKWKRFVTIE
NYFWEEIEEHRTNLDLTSEGEDLMDRFLIKQRQLKQSTGNVESFVDWQLIRNSVEIFIAG
YETTSTTLNWCCLFMSKYPDIQEKVHKEISEIIGKERLPTMNDKKALNYTQAVMDEVLRL
SSVVPMALIHRTFYDANINGFYIPKDSLIFPNLYACHMDPEIWESPTTFYPEHFLSLDSN
EISKYQPREELIPFSVGKRQCLGESLARSEYFIFFVSMVQRFQISFAEEISEEKYLQTII
GNEGHIRTSDITKFKFKKR*
>v31.001324 12-de 37% to #5 83k last exon
only
LKNSEYFIFFVSMVQRFQISFAEDISEEKYSQTIIGNEGHIRTPDIKNFQFKMRY*
>v31.001324e 13 46% to #5 89-91k
MELCYCVTFILIFLYFL
YWVCRKPPIPKGLKEIPMESGLPIIGAIHKIEPPMHHYLLKLGRKLGPIFRIKLGMRKIVVLNN
YEMIKKALIDDANNFSGRWSPKIITEVSHDSGIMFKDGQGLATQ
RSFILKVLRDFG
LGKSKSLEIIQNECLNLLDELDTLSDQIVDFSEFFPIYTTNIISRFIMNKRFTRDDPNIQ
FIWKTMDNLAKNKDIFHLILLMFPCLDQSFIVARLLFLFVSDWKRFVKIQDYFAEEIKEH
RNALDFTSEGEDLMDRFLIKQHELKQSTGNVESFVDWQLIRNSLELIIAGYETTSTTLNW
CCLFMSKYPDIQEKVHEEISEIIGKERLPTMNDKKALNYTQAVMDEVLRLSSVAPMGLMH
RTFHDANINGFYIPKDSLIFPNLYACHMDPEIWESPTTFYPEHFLSLDSNGISKYQPREE
LIPFSVGKRQCIGESLARSEYFIFFVSMVQRFQISFAEEISEEKYLQTIIGNEGHIRTSD
ITKFKFKNR*
>v31.000013:319135..327791 (- strand)
gene model mk4.000013.25 was three exons,
changed to one exon
MVIFIYILLLIFFILLLSNIRR
FYLDQTPPIGYRKLPEGKEWSFIGNLIRLFREPLWSHLYNKS
KIHGPIFKLIMGCREVIVLSSNNTICKVFKNKGVNLSERWPDILFETYNCEMNILFKDKA
WWTIRRSLILKVLKNFISKEQKLIEIVNEECLILLKDIKDVCGKEINTKELFRKSMVNIL
SKIIINLRFERESKNYKILNEIIEENSQIKNMLIKTMLLFPWLEKLPKFVRFLFWCSEYK
RNYKIQNSFFKEIIEEHKRKFDSMNKVENLIDAFLKEQNNLGENNRIIDGITDWQLIRNG
IELFIVAFEKIRTLLSWSMVLMARHSEIQERIHEEIIQLIGRDKIPNLVNKRSLPYTQAV
IDEIFRYSSLVPITLPHKITEDIELHEYLIQKNSLVFVNFYAVHRDGDVWEKPDDFYPEH
FLKLLTNGDIKYTPRDELMPFGIGSMQCLGEKFTKFQLFVILTSIVQNFKIKFRREITEE
NSNSILHETNGMIRSPLNSDVVFEMR*
>v31.008506 8 55% to # 5
MITLLNVLISIFLVIILYFLSRKFSTNPIPIGLRPLQGPS
GWPLVGNLFSIKEPLWSIFYKHAKTYGEIFKFKLGNRELVIINSSKILFKTLKDQGVNFS
GRQQNDLIKYITHDCGIVFKEKEWWSTQRSFALKVLRDFGLGKQRSIEIVNNECSILLQE
LEETSGKNICTKSCFPSVTVNIIAKLLMNMRFEK
NSSEFFEFRKIIEQTTHNRSFLVILF
QIYTLPHFTIPFIARFSGLRNHIDAVHNFVINIINERKKTFSHENEGQDFIDMFLIEKHK
LESENVKNHTFTDWQLIRMVVELFGAGFESTSTTLSWAMVLLARHTEIQDKVHQEIINLI
GVDKIPDLNNKKFLHYTQAVMDEILRISTVAPLAVPHRVFNDAEVEGFYIPKDSTIFTNL
YACHRDEKVWEKPFDFYPEHFLTKLDNGEMKYTPREELVPFSTGKRQCPGESLARLEYFV
FLTSILQKFKIKFNKAIDDITYEKITRGTDGTVRAPLDVDLIFEMRF*
>v31.023085 same as v31.008506 8 with frameshifts at &
runs off the end
MITLLNVLISIFLVIILYFLSRKFSTNPIPIGLRPLQGPS
GWPLVGNLFSIKEPLWSIFYKHAKTYGEIFKFKLGNRELVIINSSKILFKTLKDQGVNFS
GRQQNDLIKYITHDCGIVFKEKEWWSTQRSFALKVLRDFGLGKQRSIEIVNNECSILLQE
LEETSGKNICTKSCFPSVTVNIIAKLLMNMRFEK &
NSSEFFEFRKI &
QTTHNRSFLVILFQIYTLP &
HFTIP
> v31.000051 7 63% to #5
MDNFVLIFITLGIALYFIKKFFFNQSASKNLNLLQGPTGWPL
IGNINSFNEPLWMVLYKYSKHYGSLFKYTMGRRDIVILSSSKMLFKTLKEQGNNFSGRFQ
NFLIKARTRNSGILFTEKEWWATQRSFALKVLRDFGFGKQRSQEIVSNECMILLKDIEEE
CGKVVSARSLFPKATVNVIAKLVMNMRFESDSKDFTELTKLIEKAIQNNNFILTLFQMYP
ILDNMPFIAPFLLWWSGRNKTAKITSKFINNIIDDHKKRFNIENEGEDFIDIFLKEQHKL
NEEKVKNHTFTDQQLIRVVLELFFAGYETTSTTLSWSMLLLAKHPNIQEKVYQEIVDLLG
TEKLPNFADKKCLQYTQAVMDEILRVSTVVPLSISHRVFENTEVDGVYIPKDSIIFPNLF
ACHRDENVWEKPFEFYPEHFLNINNSGQLKYTPRDELVPFSIGKRQCLGEGLARIEFFIF
LTGIIQKFKIRFENEISEEEFAKITRGTDGGIRAPLSSDVVFELRI*
>v31.003543 6 95% to #5
MFTIFEVIVVIALALPIYFLSKLMTRPSIPKGLKPLQGPSGW
PLIGNLFTIKEPLWSFLYKQTFKYGPLFKFTMGCRDIVVISSNKILSKALKEKGIPFSGR
WKNIIAITLVHNSGILFTDGEWWATQRSFALKVLKDFGFGKQRSTEIISHECAFLLKEIE
ESCGKVISARSLFPKCTVNVIAKLAMNMRFERDTPNFKFLTANVERVAQNKNFIVTILLM
YPILEEYPRIAKLLLRFSGREQEFEEMHAHFRAIIEEHKKRFNVENEGEDFIDMFLREKY
ELDNEKVLNHTFTDWQLVRVIFELFVAGYETTSTTLTWTMILMAKNLEIQDKVHKEIVNI
IGSERIPNVSDKKSLPYTQAVMDEIFRVTSVVPLSLPHRLLENSEINGTFIPKNSIIFPN
LYACHRDAEVWKRPFEFYPEHFLTEESNGSIKYSPMDELVPFSIGKRQCLGEALARMEFF
IFFTSIMQRFKVKFEKEISVDAYAKMTMGTDGTIRAPLSSDVVFEIR*
>v31.010720 5
MFTIFEIIVVIVLALPIYFLSKLVTRPSIPKGLKPLQGPSGWPLIGNLFTIKEPLW
SFLYKQTFKYGPLFKFTMGCRDIVVISSNKILSKALKEKGIPFSGRWKNIIIKTIALNSG
ILFTDGEWWATQRSFALKVLKDFGFGKQRSTEIISHECAFLLKEIEESCGKVISARSLFP
KCTVNVIAKLAMNMRFERDTPNFKFLTANIERIAQNNNFIVTILLMYPILEEYPRIAKLL
LRFSGRDQEFEVIHAYFRAIVEKHKKRFNVENEGEDFIDMFLREKYELDNEKVLNHTFTD
WQLVRVIFELFIAGYETTSTTLTWAMILMAKNLEIQDKVHKEIVNIIGSERIPNVSDKKS
LPYTQAVMDEIFRVTSVVPLSLPHRLLENSEINGTFIPKNSIIFPNLYACHRDAEIWKRP
FEFYPEHFLTEESNGSIKYSPMDELVPFSIGKRQCLGEALARMEFFIFFTSIMQQFKVKF
EKEISVDAYAKMTMGTDGTIRAPLSSDVVFEIR*
Planarian clade C
>v31.008081 = AY067980 and DN308641 a
longer EST
Upstream seq for N-term part of gene this
matches v31.016521
MWQDILTGAGVGILSVFV
ILKFIERLRLPPGPWALPFWGNYRGFNGAMIYKRMVEYYKPKYGNLVTLFW
GNTPIVFINDYKLAIEALGNKNGKHLAGRKSVQT (1)
(1) EDIVSEERHNIFGNNYGPLWKEMIRALKLGVSKCGLTPSLEKNIQKSINFYCDELIRNP
DNSGKGVFPFDESYWLSDNTVLSIVIGRTFTLEDEDYIILQDSRRQVFDIMDK
(0)
SEFVNWIPFGRYLPLKCIRRLFEQSTKLNNLLAK
FVSDARKMGRYRNNPDNIIEYLLQETENSKLVTEK (2)
KVNLNDVHIRQIFKDILFASYEGIGMTNIWYMALLGLHPQIQERIRLDITKLCSKKK
DSTPKFEWKNELPYIQAVEYEFFRFSSIVGILDFHCVLKSVTLGGYHIPKGCLIAVNQ
YAINHDAERWENPETIKPERFLDSSGAFTDRSDLMPFGMGVRMCPGTSITKGYGF
LLLCNLCLNYKIKWSSENEFTELVDDPENAVLFRFPKDYLLNISKV*
>clone= H.49.4f P450 AY067980 Schmidtea
mediterranea
same as v31.008081
IGXXGGXXHFPKGXFNXXXXGRRFIXXXDXGEILEPFRLERFLDGSGAFPARFVLMP
FGMGVRMCPGPSITKGYGFLLLCNLCLNYKIKWSSENEFTELVDDPENAVLFRFPKDYLL
NISKV
In Figure S3 bottom of category 3 images is
H.49.4f
I think the table 1 number is a typo and it
should be H.49.4f
When I went to your 2002 paper on the ESTs,
the accession numbers were given
I searched Genbank for H.49.9f and did not
find any results, but H.49.4f pulled up a P450 sequence, so I think that is the
one you labeled category 3 in Table 1.
>Related gene to v31.008081
Matches EST DN295793.1
v31.019995 exons 1,2
v31.016694 exon 4
v31.029556 CDF exon 3
MNRTISSYKLPPGPNRNSDEADFIINEKLIYQKIVQKYIPKYGPIC
TLYKDGTPVVFINDIETGYEVFVRKLSKQVSGRSASY (1)
EKILSGNRNNILNSDYGPLWKTLQRN
LHKGLRHCANLDRLNEIMYKCFDKFKETVEYRRGSKNGGIEVDNDLFWMADNVITMLLFN
EIFNDVDYKKYQGAIEVIPQYAEE (0)
CDFPNDKPSKKSDFKSVEKLQKVFNQLIEVLQIRIDEHRKKGDYKIACFDITDFVLLAVEEYHLDPKSKKL
(2)
4054
GIKLTDLHVKHSLIDVIFASQEGLGNSFVWVFGLLALYPNIQENIRTEINKFRDDNNVEVTL 4239
4240
HWKSKMPYTNAVLCEIQRYASADTFTDFHSTMDDINIGPYEIPKDSLIVLNLYAIHHDK 4416
4417 KQWKNPDIIDPQNFLSEDGRSFKRRKDFVPYGLGLRTCVGNTFSENVLFVLIMLVVDNYK
4596
4597 MVWGKNKSQEIIDDKNAVFIRDVEPFNIQFIRLK* 4701
>v31.006592 2 aa diffs to v31.019995 exons
1,2 above
The rest is not in the first 9500 nucleotides
of this contig
MNRTISSYKLPPGPNRNSDEADFIINEKLIYKKIV 11776
11775 QKYIPKYGPICTLYKDGTPVVFINDIETGYEVFVRKLSKQVSGRSASYG
(1) 11638
9775
EKILSGNRNNILNSDYGPLWKTLQRNLHKGLRHCANLDRLNEIMYKCFDKFKETVEYRR 9600
9599
GSKNGGIEVGNDLFWMADNVITMLLFNEIFNDVDYKKYQGAIEVIPQYAEE (0) 9447
>v31.022901 37% to v31.019995 above in the
C-term half
top half supported by EST DN311932
MLTDLFESSVFYLC
6243
LGIVAYIIYKWHFPKKHNLPPGPKAWPIIGSIPDPYSSPLSYKRLIEDWKEKYGEIILF 6419
6420 KRMGMNFVYVSDYKLGYQAFVKDYSNELAGRPLNSV (1)
6527
6580
DRLSVGNENIFFTRSLDAGWTELRKQIMIMLRKVAEPQKMTEISNNAYELFATHIREKKE 6759
6760 LVSDGGFYVEQLCYWVGHNILVQVFWEDAVEFDNPNYQDTISVIGKLMAKVGN
(0) 6909
LAFFDITPLNCLPHPGKNKILEYSKYLSDKVQ (0)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
(2) YGQLPM
10781
LTDWFISNLSLDIYFAGMDAFGIGFSWTIGLLATHPHVQDNIRKELQKNDIENVESFNY 10957
10958
KMMDKLHYLNAVVNEVMRIHSLSSFTSFHRAMSDVKVGEYDIPKDTIIALNIYGAHYDPK 11137
11138
YWKNPNEFNPDRFINADGKFQSPKEGFMPFGVGRRTCVAERYTVKESHFIFTGRICQDFK 11317
11318 ITWSSKNKTDKVEEDLENTFFRHTAPFYVEFHPIK*
>v31.010994 2 aa diffs to v31.022901
MLTDLFESSVFYLC
LGIVAYIIYKWHFPKKHNLPPGPKAWPIIGSIPDPYSSPLSYKRLIEDWKEKYGEIILF
KRMGMNFVYVSDYKLGYQAFVKDYSNELAGR
(missing seq in a gap)
LTDWFISNLSLDIYFAGMDAFGIGFSWTIGLLATHPQVQDNIRKELQKNDIENVESFN
YKMMDKLHYLNAVVNEVMRIHSLSSFTSFHRAMSDVKVGEYDIPKDTIIALNIYGAHYDP
KYWKNPNEFNPDRFINADGKFQSPKEGFMPFGVGRRTCVAERYTVKESHFIFTGRICQDF
KITWSSKNKTDKVEEDLENTFFRHTAPFYVEFHSIK*
CYP3 clan (15 sequences, some are partials or
dulicates, 6 complete sequences))
Planarian clade D
>v31.004132b 46 heme
29599
FDSENKQNRSQFSFLPFGIGPRICIGQRFALLEAKFALVHLLKNYTILPCEKTP 29438
>v31.004132a 45 heme
43% to v31.000200 a
20881 MFGDCLFSNCSLCLILTLLFIYVLYR (2)
20739
LTTFSYNLDQKIGHEGPKPLPLIGNILDFRRHGFHVCDVRNQKRFGHLYP (2) 20590
IYIGQIGMIMVSDEVLLRQILVKEARSFIDRP (0)
19137 KFLLSSSVMKRNLIQLKGKDWDRVRTLVTPTFTSGKLKK
(0) 19021
MSPMIVASIQDMMKKFDDVKDSNINMKN (2)
18033
IFGSLTMDVIAKTMFGIDIDKSSNSSHMFIEHGKKLFNISFSSMIFMLS (1) 17887
14360
TLFPPSMGLIEYLFPRGITSPDSMTFFEKSMAVTINSRRHSNE (0)
EFHDFLALVLKSSTETGNLQHSGESTSETISYKKLTEEEILAQSIVFLLAGYETTASALN 14181
14180 FCCYYLAKNPDTQEELYNELVENLPDN (0) 14100
12595
KEITFDVLSKLNLLEQSLSETLRICPPISRFARECTKDTILTSSTGQVIQAKKGMKFVIPV 12413
12412 YAIQHDERLWPDPEKFDIHR (2) 12353
11351
FDSENKQNRSQFSFLPFGIGPRICIGQRFALLEAKFALVHLLKNYTILPCENTP (0)
KKLTFGPSGLTVVKEPVILRIEKR*
>v31.003455 b heme CYP3 like runs off the end
45% to v31.000200 c
95% to ec1.13784.001 EST (DN302691)
96% to v31.004132
MFGDCLFSNCSLCLILTLLFIYVLYR (2)
21890
LTTFSYNLDQKIGHEGPKPLPLIGNILDFRRHGFHVCDVRNQKRFGHLYP (2) 22039
IYIGQIGMIMVSDEVLLRQILVKEARSFIDRP (0)
28071 LKFLLSSSVMKRNLLNKGKDWDRVRTLVTPTFTSGKLKK
(0) 28190
MSPMIVASIQDMMKKFDDVKDSNINMKN (2)
31393
IFGSLTMDVIAKTMFGIDIDKSSNSSHMFIEHGKKLFNISFSSMIFMLS (1) 31539
ALFPPSMGLIEYLFPRGITSPDSMTFFEKSMAVTINSRRHSNE (0)
32986
EFHDFLDLVLKSSTETGNLQHSGENTNEAISYKSLTEEEILAQSIVFLLAGYETTASALT 33165
33166 FCCYYLAKNPDTQEELYNELVENLPDN (0) 33245
34803
KEITFDVLSKLNLLEQCLNEILRICPPISRFARECTKDTILTSSTGQVIQAKIGMKFVIPV 34985
34986 YAIQHDERLWPDPEKFDIHR (2) 35045
>v31.003455 a heme CYP3 like
note: the exon beginning with KEIT is exactly
the same as exon 9 of
v31.003455 b. This is probably the correct end of that gene
out of sequence
707
KEITFDVLSKLNLLEQCLNEILRICPPISRFARECTKDTILTSSTGQVIQAKIGMKFVIP 886
887 VYAIQHDERLWPDPEKFDIHR 949
8045
FDSENKQNRSQFSFLPFGIGPRICIGQRFALLEAKFALVHLLKNYTILPCEKTP 8206
8253 EKLTFGTSGLTVVKEPVILRIEKR* 8327
>v31.016958 1 aa diff to v31.003455 a
(duplicate contig)
8324 MFGDCLFSNCSLCLILTLLFIYVLYR (2)
8466
LITFSYNLDQKIGHEGPKPLPLIGNILDFRRHGFHVCDVRNQKRFGHLYP 8615
>v31.000200 a CYP3 like
MIEFISDYIYFVYFIIIIILFYK (2)
59731 LGTIKYNLHLKLGHRGPQPWPFIGNFPQILRYGFYEIDIINRQKYGNIYP
(2)
FYFGNIATSVIFDEELLKLILIKEAKCFTDRL (0)
DIGFNGKISKNMAIVLKGKNWESVRNLISPTFTSGKLRK (0)
MSPLIIDCISLLEERINSHPLEEPVDVK (1)
NFGAFSIDVIARTMFGIRIDSQTNQNNPFIVHAKNLFKFSIRTPMLLLF
(1)
FFPDTMRCIRKFIPNYEIMGRETLEYFVKQLDMAIDERQNSLE
(0)
EYNDFLTEIMKVKQEQTDKSYGNSICLTRAEIIAQLLMFL
MAGYETTASSLSYVAYFLAM NTEAQQEIYEEILKADYN (0)
100624
103629
NEITYESITNLPLLDAAINESLRLCPTVPRIDRVCTKDTVLLTSKNQKIYAKEGDVFKIPVYA
IHMDPNIWPNPHAFDIHR (2) 103871
103924 (?)
FDNENKKNRSYLSFMGFGMGPRNCVGMRFALYEMKMALVSILKRWELRSCIQTP (0) 104085
104135 QTIKIKKSSLSGLEKPILLKIHERK* 104212
>v31.000200 b CYP3 62% to v31.000200 a
MIEYFYDFKLLLCFVVIFLIYK (2)
126060
LGTLKQNLHKKLGHQGPPPLPFFGNFFDIIRHGLYELDIINRDKYGKIYP (2) 126209
126261 FYFGGIPISIVSDEELLKQILIKDAKCFTDRL (0)
126356
128465 DIGSNGKIGQKMLIILKGKSWERVRNLVSPTFTSGKLRK
(0) 128581
129215 MSPLMKDCIDLLDKRLAGIPENDPIDVKD (2)
129298
130409
VFGALTMDMIARTMFGMHIDSQTNPNNPFIINAKKLFKFSLFNPMLILI (1) 130543
130593
LFFPEITPIFRKFFPNWEFLGRQTMNFFVSNLNKAMDERKKSPE (0) 130724
135892 QYNDFLTEMMKAHKEVNDSDPEQLEILDSRSLTNSEIIAQSFLFLLAGYETTATSLTYVA
136071
136072 YFLAKNPEAQQEVYREIIKVFGTD (0) 136143
139694
EISYEKISNLPFLEAAINESLRICPPASRVDRVCTEDVVLVTSDNKQINAKKGDVFTVPI 139873
139874 YAIHMDPEIWPEPYKFDLSR 139933
140600
FDNESKKTRSIYSFMPFGMGPRNCVGMRFAVLEMKMALVNLLKQFELVPCAETL (0)
DVIKFKKTAFGGPVKPIILKIVKRS*
>v31.000200 c CYP3 like frameshift at
& in exon 9
63% to v31.000200 b
MMEFFLNYFLDIKPLLFVLGLYLFYK (2)
160265
YGQTKQNLHIKVGHKGPPPWPYIGNFIDIFRFGVHEMDIMNHKKYGNIYP (2) 160414
FYLGNIRSCIVSDEKILKQILIKEAKYFTDRL
(0)
163489 DIGFNGKSTEKMLTVLKGKDWERVRNLVSPTFTSGKLKK
(0) 163605
165274 MSPLIADGVNLLEKRIIEYPTDTPIDFKE (2)
165360
172501
FFGSLTMDVIARTMFGMHIDTQTNPKNMFMIQAKKLFNVSAINPLILIF (1) 172647
LFFPELAGLVKKIIPKWEFFGRSTFQFFNNNLYKAIEEREKLKDDGR (0)
172882 EYNDFLALMLKAHKEVDESDPNQLHNMDSKSLTNQEIMAQSLIFLLAGFETTATTLTFL
173058
173059 SYFLAKNPNYQREVYDEIVIGVD (0) 173115
181103
DEITYETLIKMRLLDAAISETLRICPPASRIDRACTQDVVLTASDGSKITAEQG & 181264
181265 DVFTVPIYSIHMDSSIWPNPNKFDIHR (2) 181346
201967 FDDENKKTRGAYSFMPFGMGPRNCVGMRFALLEVKWAIVTILQKFEIVPCPETL
202128
DELKFKKSGLTAPIKPILLKVVKRSQN*
>v31.001060 a CYP3 like
62% to v31.000200 c
MIGLLLSYIFDIKFLLAFVVVYLIYK (2)
33972
FGKQNQNLHVKLGHNGPPPLPFLGNLLDVQKMGFHTFDKMCRQKYGKLYP (2) 33823
33776 MYFGGSPMTVVGDEELLKQIMIKEFKCFTDRM (0)
33681
30268 ELAFRSKRAHKMLTVLKGKDWERVRNLITPTFTSGKLRK
(0) 30152
29939 MSPLISDGIELLKKRISNNPPDTPIDIKE (2) 29853
27056
FFGALTMDVIARTMFGMQIDSQTNPNNQFVINAKRLFTFSLFNSFVIIF (1) 26910
26858
LMFPKLGILFRKILPKWEFFGKESFQFFIDNMQMAIDERAKSTD (0) 26727
21847 KYNDFLALMKAHKKETENDSESSKLMDSKTLSNDEIMAQSLVFLLAGYETTATTLAFVSY
21668
21667 FLAKNPDAQQDLYNEIMECLGSE (0) 21599
19966
REIANDTLMTMPILDAIVCESLRICPPAVRVDRVCTQDVTLETSDKTKVCFKKGDIIAIPI 19790
19789 YAVHSDPSIWPDPEKFDYHR (2) 19730
17523 FDPDRKKTNGQYSFMPFGMGPRNCVGMRFALLEVKWAIVSILQNFEIVPCQETL
(0) 17362
EKLTFKISGLLSPISPILLKIVKRGQE*
>v31.001060 b CYP3 like
96% to v31.001060 a
MIGLLLSYIFDIKFLLAFVVVYLIYK (2)
74587
FGKQNQNLHVKLGHNGPPPLPFLGNLLDVQKMGFHTFDKMCRQKYGKLYP (2) 74438
74391 MYFGGSPMTVVGDEELLKQIMIKEFKCFTDRM (0) 74296
69116 ELAFRSKRDHKMLTDLNGKDWERVRNLITPTFTSGKLRK
(0) 69000
68787 MSPLISDGIELLKKRISNNPPNTPIDIKE (2) 68704
61335
FFGALTMDVIARTMFGLQIDSQTNPKSQFVINAKKLFTFSFFNSFVIIF (1) 61189
61142
VLFPKLGILFRKILPKWEFFGKESFQFFIDNMQMAIDERAKSTD (0) 61011
55078 KYNDFLALMMKAHKKETENDSESSKLMDSKTLSNDEIMAQSLVFLLAGYETTATTLAFVS
54899
54898 YFLAKNPDAQQDLYNEIMECLGSE (0) 54827
53204
REIPNDTLMTMPILDAIVCESLRICPPAVRVDRVCTQDVTLETSDKTKVCFKKGDIIAIPI 53022
53021 YAVHSDPSIWPDPEKFDYHR (2) 52962
38784
FDPDHKKTNGQYSFMPFGMGPRNCVGMRFALLEVKWAIVSILQNFEIVPCQETL (0) 38626
EKLTFKISVLLGPISPILLKIVKRGQE*
Planarian clade E
Two genes plus one pseudogene fragment plus
alleles
>v31.019801
36% to v31.000200 b
v31.029872 identical to v31.019801
v31.010235 a DN314674 identical to v31.019801
ec1.03053.004 100% to v31.010235 a, 100% to v31.019801
2723 MLIFVSLLLTFLSLFYFYRRRMFASFAKYNIPGPPPNFLFGNLIEYRNNTFYELLIKWQK
2902
2903 EFGKVFVYFEGPTPNVVIGDPDLLQEVMVKQFSNFHGRKLFPMQKNPDEDEK 3058
4403 VSMFLARGKRWKRLRTTINPAFSDAKMRRMFPMVDESIASFVNKLNERGDKKFDCINIQEY
4585
4586 LQRLTMDIICKCAFGVDTDCQTNVNHPFIVSLKKFLKEM 4702
6292 NLSTLKAAVVLTLAEIKPVLVYLLEAFNQRPGQRVELMKIRSTLVQVIEARRKCSEKRFDLLQ
6480
TDEEITEQTSSNQKKTSKPLTTEEVIAQANLFLFAGYETSSTALS
7520
7521 FILHSLSVYPDVQDKLFQEISRLHE (0) 7595
9947
KIEDKSIGSRELYDALGRLPYLNALIYETLRFYPFASTVIHRMCLKSEGTHLSNGLYIPQGTFV 10138
10139 IPNVFAIHYDKDIWTSVDPH (0) 10198
12108 TFSPERFLQSNGTELEFIGPPNPFAWLPFGAGPRNCIGQRFAMMVIRATLCQFVYRFQ
12281
VSSTEKTENPLKLKVGATISPINGVNIVLKKRLSY
YSFVIITTLKLNISRWMYPIQHTPLKI*
>v31.032551 N-term CYP5 like
31% to v31.000200 b 2aa diffs to ec1.03053.004,
2 aa diffs to v31.019801
possible allele
2590
MLIFVSLLLTFLSLFYFYRRRRFASFAKYNIPGPPPNFLFGNLIEYRNNTFYELLIKWQKEFGKV 2784
2785
FVYFEGPTPNVVIGDPDLLQEVMVKQFSNFHGRKLFPMQKNPDEDEK (0) 2925
4134 VSMFLARGKRWKRLRTTINPAFSDAKMRRMFPMVDESIASFVNKLNERGDKKFDCINIQE
4313
4314 YLQRLTMDIICKCAFGVDTDCQTNINHPFIVSLKKFLKEM
4433
NLSTLKAAVVLTLAEIKPVLVYLLEAFNQRPGQRVELMKIRST 5962
5963 LVQVIEARRKCSEKRFDLLQ 6022
>v31.010235 b CYP3
like 61% to v31.019801
v31.022052 40% to CYP5 heme, 36% to v31.001060 identical
to v31.010235 b
v31.013908 use to complete gap in v31.010235 b
24484
MFIFISLVVFLFTLFYVYRRRKISLFSQYNIRGPPPNFIFGNLIEYRSTVFYELFAKWERKYGKV 24678
24679
FVYFEGPTPNVVIGDPDLLQDVLVKQFSNFHGRKLFPFQKNPDEDEK (0) 24819
25019 ASMFFARGKRWKRLRSTINPAFSDSKMRRMLPLIEQSINVLMTKLHEESQKHIESIEIMDVMQRL
25214 TMDIICKCVFGIETNCQLNVNDPFIVSLKAFLGGT (0) 25318
28640
NFSSLKMALLLTFPEIKSIFIYMMERFNSGISQKINFLKIRSTLLQIINARKKSSEKRFDLLQV (1) 28828
31440
NEKEIKTNIPMPKMNSKQLTTEEVIGTATLFVFAGYDTSSMAMSYILHSLAVNYDAQNKLTSEIDEVFK (0) 31646
ELEEKNLNSWEFYDSIVKLPYLNAVIYETLRFYPFVSTIMNRMCLKSEGTHLSNGQYIPKD
TNIIVNVHSVHFDKDLWGPHDPH (0)
34909
IFYPERFLQINGDEYEFVAPTNPLIWLPFGGGPRNCIGKRLALMI 35043
IKLTLSHLIHQFRITPSQNTENPLQLKLGTTICPANGVNLGIRERLVFVFTISS*
>v31.010235 c
pseudogene fragment
19617
FSDAKMRRMFPMVDESIASFVNKLNERGDKKFDCINIQEYLQRLTMDIICKCAFGVDTDC 19438
19437 QTNVNHPFIVSLKKFLKEM 19381
>v31.019771 a
N-term CYP3 like
2 aa diffs to v31.010235 b possible allele
6603 MFIFISLVVFLFTLFYVYRRRKISLFSQYNIRGPPPNCIFGNLIEYRSTVFYELFAKWERKYGKV
6409
6408
FVYFEGPTPNVVIGDPDLLQDVLVKQFSNFHGRKLFPFQKNPDEDEK 6268
6040 ASMFFARGKRWKRLRSTINPAFSDSKMRRMLPLIEQSINVLMTKLHEESQKHIESIEIMDV
5858
5857 MQRLTMDIICKCVFGIETNCQLNVNDPFIVSLKKFLGGT
(0) 5741
2410
NFSSLKMALLLTFPEIKSIFIYMMERFNSGISQKINFLKIRSTLLQIINARKKSSEKRFDLLQV (1) 2219
>v31.019771 b N-term CYP3 like pseudogene
fragment
5 aa diffs to v31.019801
5 aa diffs to CYP10235 c probable allele of
the pseudogene
12090
FSDAKMCRMFSMVDESIASFVNKLNERGDKKFDCINIQEYLERL
12222 TMDIIC*CAFGVDTNCQTNVNHPFIVSLKKFLKEM (0)
12326
>Dugesia ryukyuensis (planarian)
BW640569.1 EST 62% to v31.019801
FIGPPHPMAWIPFGAGPRNCIGQRLAMMIIKLTLGRFINHFELVCSNKTENPLKLKIGGT
IAPVNGVHLLVKERKL*
Planarian clade F
CYP20 clan (1 sequence)
>CYP20 Schmidtea mediterranea (freshwater planarian)
NZ_AAWT01057969
34% to
Paracentrotus lividus
33% to
Strongylocentrotus purpuratus
32% to
Saccoglossus kowalevskii
25% to human CYP20
from SmedGD
database
Missing first exon
23008(2)aga KPKQIVIIPGLQKSDPK(2)
22918FGNLLEIKNSGSLHQFLSDLHLKFGAVATFYWNDQKIVSVCSNDLFKSVQDLFDRPSLI
FGNFHEFIGENCLQYANGNEGQNRRKQYDKAFQHDMIIR(2)22625
18726
YISTIENVGKSNLEEWHGSKVTVDSIEHWAYIMAVKSILKACIIPEEQSPEYCDTIITLYKS
VFIGLEKKFVECKVLSDEEEIQFQKDKNQFYSIIREIINKRLDFLENSDLENEKLLLIDY
IILYHRELNRNLIENEVLIYLIGGFHTT(1) 18274
13764(1)GNALSWCIYYLAKHPKCQEKLFTEISKRQIQLQNTSECYKLILD
LKYLKACIEETLRLSQLAPYAARVSDEDRYLSNYEVPANTPIILALGVSLKDEKI
FNNPDQFNPERFVDSNFPSFAFVPFGFAGKRKCPGER(2)13357
13304
FSYLELSIWLIQLVGKYRFTLTNPHQTVNKVYGLVTRMSENVSVQFGERSDVL*13143
Planarian clade G
>v31.00742 similar to CYP2A7, CYP2Y in the
CYP2 clan
36893
MIFFTCLFCLVCVFILTKFRRASNLPPGPIGLPFFGYLFFI (1) 36771
35352
ERPSFKSLHRLGKIYGKIFSLTICGRTVIVINELSLIKHILVNRKEFSGRTTLF (0) 35191
IGENIRENIFSHNLWTNSHRYKRTFTYKTYFGKQKRIFRQNDLICERTFSQKSC (2)
IIDEECSLLINFIKTITDEPCNSR (2)
34674
LFFNKCVSNIIWKIVFGTRFDYSSTNAILNVENVAINNTENDIITFRQLMPRTWL (0)
(unidentified seq)
31030
DKETTRLVFELFAAGTDTIILTLQWGMLLLCIHPKEQEKMRKEIEEFIITPVGEDIFISW 30851
30850 NDRQKLRYCQQ (0) 30818
26720 VIAEIHRYASVTPLALPHRALTSSKVEGFDIPYNSIVLIDIYSVHYDQNIWIEPQKFNPE
26541
26540 RFNGRSPTEKLIPFSL (1) 26493
26451 GTRTCPGSSLAQTEIFTILTNIVINYKILPVKKNLSLDDL
26332
GDGTSGLTRGPSYHELIFKKLNDKNSK* 26248
Planarian clade H
>v31.000354
31% to v31.000423
MFIQLFGAVLCFIIFYWYLIKPRNLPPGPS (1)
DSKDRSKIFDSLKKYGNIVSIRVGFSYMIILYDLDTIKEAFTVKGDQFSGRGLKLLQKEITHSK
(1)
GIISAEGKYQRDNWRFILRSLRNMGFGKMAFEEPITES (0)
FRKMVKAIDDFSAENPDSSMDFRQCLTEAVADNISQIILGVKFDKKQLLFIIERMEKIQTVPP
IFLMVNSFPILNIFL (2)
FFKYFKNVVGIEQFKNIRVPIQDMIKKFITNHKETFDSNNIRDFIDCYINEQPEHQSTEEESYWWD
(1)
DEQIKHACTDLIAAGIGTTESTISWVLFSLANDQDWQKKVANEIDSVIGNERFPSMKDLAN
LPICEATILETLR (2)
FSSLAATGIPHTATEDSNLHEYFIPKDAIVLSYLMEVARNKDVWPDPDNFNPAANFLNSA
QNQIINRDKIIPFGVG (2)
RRSCIGESLARMEITLFFIALFQKYTVSLDPKFGMAKVAPLIFRILNHRVLKFQSRI*